Grifols International, S.A. news
- Grifols and the Public Investment Fund of Saudi Arabia (PIF) have executed a non-binding term sheet to build a network of plasma collection centers and other facilities for the production of plasma medicines, including a plasma fractionation plant and a purification plant, in Saudi Arabia.
- Following definitive agreements being signed, the project would be executed through
Grifols has adopted several measures aimed at reinforcing its strong commitment to its main stakeholders in regards to the new situation posed by the coronavirus (COVID-19) outbreak.
At Grifols, we believe this current and extraordinary situation requires companies to strive more than ever to serve patients and society in a responsible manner.
Grifols first responsibility is with its patients a
Grifols today announces that it has entered into a formal collaboration with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA) and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to tr
- Fourth straight year in which the prestigious healthcare research firm selects PharmacyKeeper Verification as the No. 1 Category Leader for Intravenous (IV) Workflow Management
- PharmacyKeeper Verification is a strategic part of Grifols’ inclusiv portfolio, offering integrated technology, software and service solutions dedicated to advancing quality and safety in pharmacy operations
Grifols (MCE:GRF, MCE:GRF.P NASD
- A participant in the Profarma Plan since 1991, Grifols received the highest possible rating in 2019 in recognition of its solid commitment to R+D+i
- Grifols increased its R+D+i investments in 2019 by 12.9% to EUR 329 million, allocating a total of EUR 1,500 million to this area over the last five years
- The Profarma Plan is jointly managed by the Spanish Ministry of Economy, Industry and Competitiveness and Ministry of Health, Social Services and Equality to bo